Back
Arbutus Biopharma Corp. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
41
ABUS
Arbutus Biopharma Corp.
Last Price:
$4.43
Seasonality Move:
19.24%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Arbutus Biopharma Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.35 | Buy |
| 20-day SMA: | 4.43 | Sell |
| 50-day SMA: | 4.44 | Sell |
| 200-day SMA: | 3.7 | Buy |
| 8-day EMA: | 4.37 | Buy |
| 20-day EMA: | 4.4 | Buy |
| 50-day EMA: | 4.36 | Buy |
| 200-day EMA: | 3.88 | Buy |
Arbutus Biopharma Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 50.6 | Buy |
| Chaikin Money Flow: | 417438 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.29 - 4.63) | Sell |
| Bollinger Bands (100): | (3.57 - 4.59) | Buy |
Arbutus Biopharma Corp. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arbutus Biopharma Corp. Stock
Is Arbutus Biopharma Corp. Stock a Buy?
-
Arbutus Biopharma Corp. share price is 4.42 while ABUS 8-day simple moving average is 4.35, which is a Buy signal.
-
The stock price of ABUS is 4.42 while Arbutus Biopharma Corp. 20-day SMA is 4.43, which makes it a Sell.
-
Arbutus Biopharma Corp. 50-day simple moving average is 4.44 while ABUS share price is 4.42, making it a Sell technically.
-
ABUS stock price is 4.42 and Arbutus Biopharma Corp. 200-day simple moving average is 3.70, creating a Buy signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
41
Arbutus Biopharma Corp. (ABUS)
is a Sell
Is Arbutus Biopharma Corp. a Buy or a Sell?
-
Arbutus Biopharma Corp. stock is rated a SellThe current Arbutus Biopharma Corp. [ABUS] share price is $4.42. The Score for ABUS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Corp. Stock Info
Market Cap:
850.1M
Price in USD:
4.42
Share Volume:
730.5K
Arbutus Biopharma Corp. 52-Week Range
52-Week High:
5.10
52-Week Low:
2.71
Sell
41
Arbutus Biopharma Corp. (ABUS)
is a Sell
Arbutus Biopharma Corp. Share Price Forecast
-
What is the Arbutus Biopharma Corp. stock price today?The Arbutus Biopharma Corp. stock price is 4.42 USD today.
-
Will ABUS stock go up or go down?Arbutus Biopharma Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is Arbutus Biopharma Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma Corp. is overvalued.
Is Arbutus Biopharma Corp. Stock a Buy?
-
Arbutus Biopharma Corp. share price is 4.42 while ABUS 8-day exponential moving average is 4.37, which is a Buy signal.
-
The stock price of ABUS is 4.42 while Arbutus Biopharma Corp. 20-day EMA is 4.40, which makes it a Buy.
-
Arbutus Biopharma Corp. 50-day exponential moving average is 4.36 while ABUS share price is 4.42, making it a Buy technically.
-
ABUS stock price is 4.42 and Arbutus Biopharma Corp. 200-day simple moving average is 3.88, creating a Buy signal.
Fundamental Analysis of Arbutus Biopharma Corp.
Is Arbutus Biopharma Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.02 per share.
Technical Analysis of Arbutus Biopharma Corp.
Should I short Arbutus Biopharma Corp. stock?
-
ABUS Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Arbutus Biopharma Corp. is a Sell
-
Arbutus Biopharma Corp. Relative Strength Index (RSI) is 50.6, which suggest Arbutus Biopharma Corp. is overbought
-
The Bollinger Bands (25) for Arbutus Biopharma Corp. is (4.29 - 4.63), which suggest Arbutus Biopharma Corp. is a Buy
-
The Bollinger Bands (100) for Arbutus Biopharma Corp. is (3.57 - 4.59), which suggest Arbutus Biopharma Corp. is a Buy
* Arbutus Biopharma Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.